Effect of raloxifene on bone mineral density and biochemical markers of bone turnover in Japanese postmenopausal women with osteoporosis: results from a randomized placebo-controlled trial
- 29 August 2003
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Osteoporosis International
- Vol. 14 (10), 793-800
- https://doi.org/10.1007/s00198-003-1424-1
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Efficacy of Raloxifene on Vertebral Fracture Risk Reduction in Postmenopausal Women with Osteoporosis: Four-Year Results from a Randomized Clinical TrialJournal of Clinical Endocrinology & Metabolism, 2002
- Early effects of raloxifene on clinical vertebral fractures at 12 months in postmenopausal women with osteoporosis.Archives of Internal Medicine, 2002
- Raloxifene and Cardiovascular Events in Osteoporotic Postmenopausal WomenJama-Journal Of The American Medical Association, 2002
- Relationships Between Bone Mineral Density and Incident Vertebral Fracture Risk with Raloxifene TherapyJournal of Bone and Mineral Research, 2002
- Uterine effects of 3-year raloxifene therapy in postmenopausal women younger than age 60Obstetrics & Gynecology, 2000
- Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With RaloxifeneResults From a 3-Year Randomized Clinical TrialJama-Journal Of The American Medical Association, 1999
- Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosisJournal of Bone and Mineral Research, 1996
- Dual X-ray absorptiometry quality control: Comparison of visual examination and process-control chartsJournal of Bone and Mineral Research, 1996
- The diagnosis of osteoporosisJournal of Bone and Mineral Research, 1994
- Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative UltracentrifugeClinical Chemistry, 1972